Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Business Journal.
Press releases published on August 7, 2025
Pattern Computer Granted Indian Patent for Novel Cancer Therapy Candidate PCI020302
GlobeNewswire
·
August 7, 2025
REDMOND, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in pattern discovery, today announced that the Indian Patent Office has granted a new patent titled "Therapeutic Compositions and …
Biodesix Announces Second Quarter 2025 Results and Highlights
GlobeNewswire
·
August 7, 2025
Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance of $80-85 million; Conference Call and Webcast Today at 4:30 p.m. …
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 7, 2025
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory stock option to purchase 100,000 shares of common stock to John …
Pixalate’s July 2025 United Kingdom Publisher Rankings: Top Mobile ‘Gaming’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store
GlobeNewswire
·
August 7, 2025
London, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the United Kingdom July 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic Quality on the …
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
-- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional …
Trupanion Reports Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
SEATTLE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2025. “The second quarter was one of the …
Trisura Group Reports Second Quarter 2025 Results: 21% Growth in BVPS and Significant Progress in Surety Expansion
GlobeNewswire
·
August 7, 2025
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU), a leading specialty insurance provider, today announced financial results for the second quarter of 2025. David Clare, President and CEO of Trisura, …
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
August 7, 2025
Presented updated data at ASCO showing consistency with prior data, including 10.3-month median PFS and 39% ORR in patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Initiated Phase 3 ReDiscover-2 trial in Q2 Approximately $657 million in cash …
Runway Growth Finance Corp. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Delivered Total and Net Investment Income of $35.1 million and $13.9 million, Respectively Investment Portfolio of $1.0 billion Conference Call Today, Thursday, August 7, 2025 at 5:00 p.m. ET MENLO PARK, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Runway …
NCS Multistage Holdings, Inc. to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 7, 2025
HOUSTON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) announced today that Ryan Hummer, Chief Executive Officer, is scheduled to present in the following upcoming investor conferences: EnerCom …
INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes
GlobeNewswire
·
August 7, 2025
BOCA RATON, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its …
Allbirds Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Delivers Second Quarter Results in Line with and Above Guidance Ranges Revises Full Year 2025 Revenue Outlook and Reiterates Adjusted EBITDA Guidance Product, Marketing and Customer Experience Initiatives Expected to Fuel Revenue Growth in Q4 2025 SAN …
Nutanix Announces Date and Conference Call Information for Fiscal Fourth Quarter and Fiscal Year 2025 Financial Results
GlobeNewswire
·
August 7, 2025
SAN JOSE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the fiscal fourth quarter and fiscal year 2025, which ended July 31, …
BioAtla Reports Second Quarter 2025 Financial Results and Highlights Recent Progress
GlobeNewswire
·
August 7, 2025
CAB-EpCAM x CAB-CD3 bispecific T-cell engager (TCE) (BA3182) Phase 1 dose-escalation study ongoing, currently dosing 1.2 mg cohort; Phase 1 data readout expected 2H 2025 Fast Track Designated Ozuriftamab vedotin (Oz-V; CAB-ROR2-ADC) Phase 2 study ongoing; …
Alector Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
On track to report topline data by mid-Q4 2025 from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN, a severe, rare form of dementia with no approved treatments Ongoing Phase 2 PROGRESS-AD trial of AL101 in early Alzheimer’s disease …
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
Regulatory Interactions and Commercial, Medical and Corporate Preparations On-Track for PALSONIFY™ (paltusotine) New Drug Application with September 25, 2025 PDUFA Date Continued Progress on the Global Development Program for Atumelnant Across …
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
BOTHELL, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results …
Regeneron Announces Investor Conference Presentations
GlobeNewswire
·
August 7, 2025
TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Cantor Global Healthcare Conference 2025 at 1:35 p.m. ET on Wednesday, September 3, 2025 2025 Wells Fargo …
Inuvo Posts 25% Growth in the Second Quarter 2025
GlobeNewswire
·
August 7, 2025
LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced its financial results for the second quarter and six-month period ended June 30, 2025. …
Resolute Holdings Reports Second Quarter 2025 Results
GlobeNewswire
·
August 7, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Resolute Holdings Management, Inc. (“Resolute Holdings”) (Nasdaq: RHLD), an operating management company responsible for providing management services to CompoSecure Holdings, L.L.C. (“CompoSecure Holdings”), a …